NR4A3 and acute myeloid leukemia: Two RUNX1 mutations, R139X and R174Q, found in FPD/AML pedigrees result in decreased active RUNX1 and dramatically reduce NR4A3 activity as measured in a luciferase reporter assay (Bluteau et al., 2011).